$REGN REGENERON PHARMACEUTICALS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in REGENERON PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
REGENERON PHARMACEUTICALS, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Aberman Michael S | SVP Strategy Investor Relation | 9,193 | 3,288,244 | Jun 23 2017 | |||
| BAKER CHARLES A | Director | 11,000 | 3,934,590 | Oct 03 2017 | |||
| Bassler Bonnie L | Director | 3,202 | 1,145,323 | Jun 22 2020 | |||
| BROWN MICHAEL S | Director | 3,371 | 1,205,773 | Jan 27 2021 | |||
| BROWN MICHAEL S | Director | 18,349 | 6,563,254 | Jan 05 2015 | |||
| COLES N ANTHONY | Director | 654 | 233,929 | Nov 13 2020 | |||
| Dworkin Peter | VP Investor Relations & Commun | 0 | 0 | Dec 22 2009 | |||
| Fenimore Christopher R. | VP Controller | 19,352 | 6,922,017 | Dec 11 2020 | |||
| GILMAN ALFRED G | Director | 8,912 | 3,187,733 | Aug 07 2015 | |||
| GILMAN ALFRED G | Director | 0 | 0 | Jan 05 2015 | |||
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 22,400 | 8,012,256 | Sep 19 2003 | |||
| GOLDBERG MURRAY A | SVP Administration & Asst Secr | 64,436 | 23,048,113 | Dec 18 2014 | |||
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 36,516 | 13,061,408 | Dec 28 2005 | |||
| GOLDSTEIN JOSEPH L | Director | 14,855 | 5,313,485 | Oct 06 2020 | |||
| GULER HANS PETER | VP Clinical Programs | 10,530 | 3,766,476 | Oct 12 2004 | |||
| INGRAM ROBERT A | Director | 1,500 | 536,535 | May 27 2015 | |||
| INGRAM ROBERT ALEXANDER | Director | 0 | 0 | Jan 05 2015 | |||
| KOLINSKI STUART | SVP General Counsel and Secret | 16,329 | 5,840,720 | Jun 07 2010 | |||
| Landry Robert E | EVP Finance CFO | 25,903 | 9,265,244 | Dec 11 2020 | |||
| LAROSA JOSEPH J | EVP General Counsel and Secret | 16,368 | 5,854,670 | Dec 11 2020 | |||
| LAROSA JOSEPH J | SVP General Counsel and Secret | 10,000 | 3,576,900 | Dec 18 2014 | |||
| McCorkle Douglas S | VP Controller and Asst Treasur | 6,866 | 2,455,900 | Dec 29 2015 | |||
| McCorkle Douglas S | VP, Controller and Asst. Treas | 0 | 0 | Nov 06 2007 | |||
| McCourt Marion | EVP Commercial | 18,038 | 6,452,012 | May 10 2021 | |||
| MURPHY ANDREW J | EVP Research | 55,421 | 19,823,537 | Dec 11 2020 | |||
| NOVARTIS PHARMA AG | 10% Owner | 0 | 0 | Nov 10 2005 | |||
| POON CHRISTINE A | Director | 16,433 | 5,877,920 | Aug 31 2020 | |||
| POON CHRISTINE A | Director | 655 | 234,287 | Jan 05 2015 | |||
| Powchik Peter | SVP Clinical Development & Reg | 2,459 | 879,560 | Dec 19 2016 | |||
| REGENERON PHARMACEUTICALS INC | 10% Owner | 2,097,314 | 750,188,245 | Feb 18 2021 | |||
| ROBERTS WILLIAM | VP Reg Dev & Med Safety | 13,447 | 4,809,857 | Sep 20 2013 | |||
| RUPP RANDALL | SVP, Manufacturing | 4,253 | 1,521,256 | Sep 16 2003 | |||
| RUPP RANDALL | SVP, Manufuring Operations | 3,983 | 1,424,679 | Apr 17 2007 | |||
| RYAN ARTHUR F | Director | 23,782 | 8,506,584 | Feb 02 2021 | |||
| RYAN ARTHUR F | Director | 47,500 | 16,990,275 | Jan 05 2015 | |||
| Sanofi | 10% Owner | 20,208,841 | 7,228,500,337 | May 21 2014 | |||
| Sanofi | 10% Owner | 22,859,144 | 8,176,487,217 | Dec 29 2014 | |||
| SANOFI-AVENTIS | 10% Owner | 279,766 | 100,069,501 | Jun 11 2020 | |||
| SANOFI-AVENTIS | 10% Owner | 15,816,953 | 5,657,565,919 | Oct 14 2010 | |||
| SCHLEIFER LEONARD S | President & CEO | 599,499 | 214,434,797 | Jan 05 2021 | |||
| SCHLEIFER LEONARD S | President & CEO | 42,087 | 15,054,099 | Dec 18 2014 | |||
| SCHLEIFER LEONARD S | Chief Exec Officer & President | 91,665 | 32,787,654 | Sep 15 2006 | |||
| SCHLEIFER LEONARD S | Chief Exec Officer & President | 61,665 | 22,056,954 | Nov 08 2006 | |||
| SCHLEIFER LEONARD S | President & CEO | 0 | 0 | Jan 05 2015 | |||
| SHOOTER ERIC M | Director | 0 | 0 | Sep 15 2003 | |||
| SHOOTER ERIC M | Director | 0 | 0 | Feb 13 2014 | |||
| SING GEORGE L | Director | 54,663 | 19,552,408 | Jan 05 2021 | |||
| STAHL NEIL | EVP Research and Development | 20,979 | 7,503,979 | Dec 11 2020 | |||
| STAHL NEIL | SVP Research and Development S | 6,541 | 2,339,650 | Dec 18 2014 | |||
| Terifay Robert J | EVP Commercial | 25,214 | 9,018,796 | Dec 13 2017 | |||
| Tessier-Lavigne Marc | Director | 2,078 | 743,280 | Jan 05 2021 | |||
| Tessier-Lavigne Marc | Director | 1,187 | 424,578 | Jan 05 2015 | |||
| VAGELOS P ROY | Director | 239,009 | 85,491,129 | Feb 24 2021 | |||
| Van Plew Daniel P | EVP & General Mgr Industrial O | 21,931 | 7,844,499 | Dec 11 2020 | |||
| YANCOPOULOS GEORGE | President and Chief Scientific | 880,938 | 315,102,713 | Dec 31 2020 | |||
| YANCOPOULOS GEORGE | President Regeneron Laboratori | 569,588 | 203,735,932 | Dec 18 2014 | |||
| Zoghbi Huda Y | Director | 891 | 318,702 | Jan 05 2021 |